·nutrition

Stop Calling Fiber "Nature's Ozempic." Ozempic Is Copying It.

Your gut already makes GLP-1. The drug turns it up a thousandfold. A fiber-first diet keeps the original signal working at its natural volume.

By Geordie Everitt

Your small intestine has been making GLP-1 since before anyone thought to bottle it. The hormone is released by cells lining the lower gut when food arrives, and it does the things that made semaglutide famous: it slows the stomach, steadies blood sugar, and tells the brain the meal is over.

So when social media announces that psyllium, berberine, or a probiotic is "nature's Ozempic," the claim isn't absurd on its face. Fiber really does raise GLP-1.

The trouble is the size of the raise.

A matter of three zeros

After a meal, your natural GLP-1 peaks somewhere around 10 to 42 picomoles per liter, according to a 2024 review in the American Journal of Clinical Nutrition. It arrives in brief pulses. The enzyme that clears it cuts its half-life to a minute or two.

Semaglutide at the Wegovy dose holds your blood at about 75 nanomoles per liter, around the clock, per the FDA label.

A nanomole is a thousand picomoles. Even after allowing for the fact that the drug binds heavily to blood proteins and is somewhat weaker per molecule, the gap is roughly three orders of magnitude, and it never switches off.

The outcomes follow the arithmetic. Semaglutide produced about 15 percent weight loss at 68 weeks in its pivotal trial. Tirzepatide reached about 21 percent. Fiber trials tend to report a kilogram or two, or simply a failure to gain weight the placebo group did gain.

Fiber isn't Ozempic. It isn't close.

What fiber actually does

The mechanism is well established. Gut bacteria ferment fiber into short-chain fatty acids, and those fatty acids bind to receptors on the very cells that release GLP-1 and its sister hormone PYY. In mice lacking those receptors, the effect disappears.

In humans, the results are real but uneven, and the unevenness is instructive.

Whole, intact foods do best. In a 2023 study, bread made with chickpea flour that kept its plant cells intact roughly doubled the GLP-1 response compared with ordinary white bread. Barley kernels eaten at dinner raised GLP-1 at the next morning's breakfast and cut how much people ate at lunch. Researchers call it the second-meal effect: bacteria working the night shift.

Isolated fibers mostly disappoint. A psyllium-enriched meal suppressed GLP-1 release. High-viscosity oat beta-glucan did nothing for it. Resistant starch added to a refined breakfast lowered it. A 2026 review of 52 trials found only some fiber types reliably moved the hormone at all.

The explanation lies in where the hormone-releasing cells live: mostly in the lower small intestine and colon. Refined food is absorbed high up and never reaches them. Starch sealed inside intact plant cells survives the trip. Thick gels, by contrast, can slow things so much that nutrients linger in the upper gut, and the signal never fires.

What works isn't fiber as an additive. It's food that still has its structure.

About those miracle products

Psyllium helps with regularity and modest weight loss, through bulk and fullness. Its acute GLP-1 data point the wrong way.

Berberine raises GLP-1 in rodents. Human data are small and partly industry-funded, and weight-loss meta-analyses range from nothing to about two kilograms. UCLA Health has publicly rejected the "nature's Ozempic" label.

The "GLP-1 probiotic" leans on mouse research into a protein made by the gut bacterium Akkermansia. The finished product has no published human trial showing it raises GLP-1.

None of these is a scam, exactly. Each is a real mechanism marketed at the volume of a drug.

The signal, not the megadose

Here is the framing I think survives scrutiny.

GLP-1 drugs are a pharmacological megadose of a signal your gut is designed to send after every fiber-intact meal. The drug is a loudspeaker bolted to the side of a system that was built to whisper.

A fiber-first diet doesn't turn up the volume. It keeps the whisper working, meal after meal, the way it did for most of human history. Our ancestors ate an estimated 50 to 100 grams of fiber a day, every gram of it still attached to the food it grew in. The average American now eats about 15.

The whisper also has a long reach. Fiber-rich eating is associated with 15 to 30 percent lower rates of heart disease, type 2 diabetes, colorectal cancer, and early death, according to a 2019 meta-analysis commissioned by the World Health Organization. No prescription required, no refill date, and no cliff at the end.

That last point matters. When people stop semaglutide, they regain about two-thirds of the lost weight within a year. A 2026 BMJ meta-analysis projected a return to starting weight in about a year and a half. The loudspeaker goes quiet, and the room was never rewired.

If you're on the drug

Nothing here is an argument to stop a prescription. For many people with established obesity or diabetes, these medications are doing work that diet alone hasn't managed.

But they make fiber more important, not less. Studies of people on GLP-1 drugs find them eating roughly 7 to 15 grams of fiber a day, with almost nobody meeting the target. They're eating less of everything, including the foods that carry the nutrients.

The practical version is gentle. Start with soluble, soft fibers, such as lentils, oats, cooked vegetables, and berries. Add a few grams a week. Drink more water than you think you need. Skip the giant raw salads while the dose is still climbing, because these drugs slow the stomach and bulky meals can make nausea worse.

And think about the landing. Whether the drug is a bridge or a lifetime companion, the diet underneath it is the part you get to keep.

Fiber isn't Ozempic. It's what Ozempic is imitating. The more interesting question is why we let the original go quiet in the first place.

← Back to Blog